RPAM
Rhenman & Partners Asset Management Portfolio holdings
AUM
$791M
This Quarter Return
+15.44%
1 Year Return
+12.81%
3 Year Return
+98.32%
5 Year Return
+175.58%
10 Year Return
+579.5%
AUM
$855M
AUM Growth
+$855M
(-2.3%)
Cap. Flow
-$110M
Cap. Flow
% of AUM
-12.86%
Top 10 Holdings %
Top 10 Hldgs %
29.46%
Holding
101
New
12
Increased
18
Reduced
37
Closed
8
Top Buys
| 1 |
LivaNova
LIVN
|
$11.7M |
| 2 |
Exact Sciences
EXAS
|
$8.66M |
| 3 |
ABMD
Abiomed Inc
ABMD
|
$7.76M |
| 4 |
MacroGenics
MGNX
|
$7.64M |
| 5 |
Nektar Therapeutics
NKTR
|
$7.37M |
Top Sells
| 1 |
Biogen
BIIB
|
$18.1M |
| 2 |
Incyte
INCY
|
$14.3M |
| 3 |
CELG
Celgene Corp
CELG
|
$14.2M |
| 4 |
SAGE
Sage Therapeutics
SAGE
|
$13.6M |
| 5 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$12.7M |
Sector Composition
| 1 | Healthcare | 93.64% |
| 2 | Technology | 0.15% |
| 3 | Energy | 0.14% |
| 4 | Financials | 0.1% |
| 5 | Communication Services | 0.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
UnitedHealth
UNH
$281B
| $30.5M | 3.57% | 123,400 -2,996 | -2% | -$741K |
|
2
Jazz Pharmaceuticals
JAZZ
$7.75B
| $26.8M | 3.13% | 187,171 +21,353 | +13% | +$3.05M |
|
3
Vertex Pharmaceuticals
VRTX
$100B
| $26.6M | 3.11% | 144,400 +11,975 | +9% | +$2.2M |
|
|
ABMD
4
DELISTED
Abiomed Inc
ABMD
| $26.4M | 3.09% | 92,493 +27,183 | +42% | +$7.76M |
|
5
Cigna
CI
$80.3B
| $25.7M | 3% | 159,691 | – | – |
|
|
HZNP
6
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $24.8M | 2.91% | 939,973 -6,087 | -0.6% | -$161K |
|
|
7
Nektar Therapeutics
NKTR
$568M
| $24.7M | 2.89% | 734,445 +219,445 | +43% | +$7.37M |
|
|
8
LivaNova
LIVN
$3.08B
| $23.4M | 2.74% | 240,600 +120,000 | +100% | +$11.7M |
|
9
NovoCure
NVCR
$1.38B
| $21.9M | 2.56% | 454,647 -90,353 | -17% | -$4.35M |
|
10
Elevance Health
ELV
$71.8B
| $21.1M | 2.47% | 73,645 -5,000 | -6% | -$1.43M |
|
11
Abbott
ABT
$231B
| $20.7M | 2.43% | 259,552 -5,000 | -2% | -$400K |
|
12
BioMarin Pharmaceuticals
BMRN
$11.2B
| $20.6M | 2.41% | 231,549 +55,000 | +31% | +$4.89M |
|
13
Humana
HUM
$36.5B
| $20.5M | 2.4% | 77,000 -5,400 | -7% | -$1.44M |
|
14
Esperion Therapeutics
ESPR
$448M
| $19.3M | 2.25% | 479,767 +125,806 | +36% | +$5.05M |
|
15
CVS Health
CVS
$92.8B
| $19.1M | 2.23% | 353,868 -55,000 | -13% | -$2.97M |
|
16
Becton Dickinson
BDX
$55.3B
| $18.7M | 2.19% | 75,000 -40,000 | -35% | -$9.99M |
|
17
Glaukos
GKOS
$5.5B
| $18.5M | 2.16% | 235,579 -5,000 | -2% | -$392K |
|
|
ALXN
18
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $18.4M | 2.16% | 136,466 -93,963 | -41% | -$12.7M |
|
|
19
MacroGenics
MGNX
$112M
| $17.4M | 2.03% | 967,186 +425,000 | +78% | +$7.64M |
|
20
Neurocrine Biosciences
NBIX
$13.8B
| $15.6M | 1.82% | 177,091 -24,000 | -12% | -$2.11M |
|
21
Medtronic
MDT
$119B
| $15.4M | 1.8% | 168,842 -131,561 | -44% | -$12M |
|
|
ARRY
22
DELISTED
Array Biopharma Inc
ARRY
| $14.8M | 1.73% | 607,070 -90,300 | -13% | -$2.2M |
|
23
Boston Scientific
BSX
$156B
| $14.1M | 1.65% | 367,908 -10,000 | -3% | -$384K |
|
|
AGN
24
DELISTED
Allergan plc
AGN
| $13M | 1.52% | 88,600 -10,000 | -10% | -$1.46M |
|
25
Eli Lilly
LLY
$657B
| $12.8M | 1.5% | 98,695 -25,000 | -20% | -$3.24M |
|